NYSE · RVTY

Revvity, Inc.

$110.47 -$2.70 (-2.39%) 1D After hours

Key Metrics

$12.32B
Market cap
51.42×
P/E · TTM
$2.90B
Revenue · TTM
$239.68M
Net income
EPS · TTM $1.99
Dividend yield 0.3%
Free cash flow $492.69M
Beta · 1Y 1.35
EBITDA · TTM $678.86M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 28
    Money has been moving out of its sector (Technology).

    Technology has run -4.1 points vs SPY over four weeks, ranking 8→2→11→7 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$12.32B
Enterprise value$14.67B
Shares outstanding111.6M
52-wk range$81.22 – $118.30
Avg volume · 20D1.0M
Net cash −$2.35B
Book value / share$59.74
IndustryLaboratory Analytical Instruments
ExchangeNYSE
About Revvity, Inc.
IPO dateJun 1, 1972
Employees11000

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E51.42
P/S4.25
P/FCF25.01
EV/EBITDA21.61
EV/Sales5.05
Graham №$51.76

Profitability

Gross
Operating 9.2%
Net 8.3%
FCF 17.0%
ROE / ROIC 3.2% · 2.5%

Financial Health

Current ratio1.72
Quick ratio1.41
Debt / equity0.45
Debt / EBITDA 4.73
Net cash −$2.35B
Working capital$889.67M

Cash Flow · TTM

Operating CF $570.01M
Capex −$77.32M
Free cash flow $492.69M
Buybacks $753.72M
Dividends paid $32.21M
Shareholder yield 6.4%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

2.7
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$51.76 vs $110.47
Trades 2.1× above classic defensive value — priced for growth
Fundamentals through 2026-04-05 · computed by TickerWolf from SEC filings